Hepatitis B immunoglobulin (Lanzhou Lansheng)
乙型肝炎人免疫球蛋白（兰州兰生）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHepatitis B immunoglobulin (Lanzhou Lansheng)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLanzhou Lansheng Blood Products Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesLanzhou Lansheng Blood Products Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A